Schonfeld Strategic Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-75,244	Closed	-$676K	–	2530
2025 Q4	$676K	Buy	75,244 +56,797	+308%	+$782K	﹤0.01%	1273
2025 Q3	$319K	Buy	+18,447	New	+$227K	﹤0.01%	1827
2025 Q2	–	Sell	-41,590	Closed	-$296K	–	2391
2025 Q1	$296K	Sell	41,590 -103,912	-71%	-$1.05M	﹤0.01%	1793
2024 Q4	$1.7M	Buy	145,502 +10,223	+8%	+$160K	0.01%	899
2024 Q3	$2.78M	Sell	135,279 -51,161	-27%	-$1.18M	0.02%	751
2024 Q2	$4.17M	Buy	186,440 +160,719	+625%	+$3.83M	0.03%	614
2024 Q1	$708K	Buy	+25,721	New	+$714K	0.01%	1350
2023 Q4	–	Sell	-10,960	Closed	-$347K	–	2118
2023 Q3	$347K	Sell	10,960 -39,118	-78%	-$1.52M	﹤0.01%	1300
2023 Q2	$2.04M	Buy	50,078 +12,851	+35%	+$521K	0.02%	748
2023 Q1	$1.39M	Buy	+37,227	New	+$1.46M	0.01%	812
2022 Q4	–	Sell	-21,970	Closed	-$1.23M	–	2880
2022 Q3	$1.23M	Sell	21,970 -22,930	-51%	-$1.42M	0.01%	1136
2022 Q2	$2.32M	Buy	44,900 +21,000	+88%	+$1.07M	0.02%	701
2022 Q1	$1.74M	Buy	+23,900	New	+$2.02M	0.02%	790
2021 Q3	–	Sell	-5,000	Closed	-$810K	–	2383
2021 Q2	$810K	Buy	+5,000	New	+$389K	0.01%	1000
2021 Q1	–	Sell	-31,880	Closed	-$1.73M	–	2033
2020 Q4	$1.73M	Buy	+31,880	New	+$1.16M	0.02%	635
2018 Q1	–	Sell	-11,424	Closed	-$220K	–	918
2017 Q4	$220K	Buy	+11,424	New	+$264K	0.02%	653
2016 Q3	–	Sell	-10,443	Closed	-$223K	–	501
2016 Q2	$223K	Buy	+10,443	New	+$278K	0.05%	364